Why the study?
What are the rates of routine CKD testing with uACR and eGFR among at-risk U.S. adults with diabetes and hypertension?
What are the rates of routine CKD testing with uACR and eGFR among at-risk U.S. adults with diabetes and hypertension?
Despite guideline recommendations, routine testing for CKD with uACR and eGFR remains low in at-risk U.S. adults, highlighting a significant gap in clinical care.
Low testing rates signal a care gap in high-risk adults; leaves open barriers and effective interventions to improve screening.
Despite guideline recommendations, testing for CKD with uACR and eGFR in U.S. adults with diabetes and hypertension is low in routine clinical care. These data highlight the need for strategies to improve routine CKD assessment nationwide.
No takes yet. Share an insight, caveat, or question.
Alfego et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: